News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
Model Medicines Announces Breakthroughs in AI-Driven Drug Discovery: Two New Preprint Papers Showcase Innovations in Novel Chemistry and Biology
Wednesday, April 10, 2024Model Medicines a prominent company in the field of human health specializing in AIdriven drug discovery has released two significant preprint papers on bioRxiv outlining major advancements
Vivet Therapeutics Administers First Patient Dose in Cohort 2 of Phase 1/2 GATEWAY Clinical Trial for Wilson Disease Treatment
Tuesday, April 09, 2024Vivet Therapeutics has achieved a significant milestone in its effort to address Wilson Disease a rare inherited liver metabolic disorder characterized by the accumulation of toxic copper levels
AustinPx Boosts Drug Development Through Investments in Pharmaceutics and Manufacturing
Monday, April 08, 2024AustinPx a prominent contract development and manufacturing organization specializing in enhancing the bioavailability of orally administered small molecule drug candidates has recently acquired advanced
Aethon Therapeutics Enters Collaboration with Revolution Medicines to Explore and Develop Innovative Antibody Programs
Friday, April 05, 2024Aethon Therapeutics a biotechnology company has partnered with Revolution Medicines Inc a clinicalstage oncology company to collaborate on novel antibody therapeutics for cancer treatment
Odyssey Therapeutics Announces Partnership to Drive AI-Powered Small Molecule Drug Discovery
Friday, April 05, 2024Odyssey Therapeutics Inc a pioneering biotechnology company specializing in nextgeneration precision medicines announced a significant research collaboration with Janssen Pharmaceutica
MiNA Therapeutics and Nippon Shinyaku Team Up to Develop RNAa Therapeutics for Rare Neurodegenerative Diseases
Friday, April 05, 2024MiNA Therapeutics a leader in small activating RNA therapeutics has announced a collaborative research and licensing agreement option with Nippon Shinyaku Co Ltd
SimBioSys and General Inception Form Strategic Partnership to Speed Up Cancer Drug Development
Thursday, April 04, 2024SimBioSys a leader in precision oncology and General Inception a global company Igniter have announced a strategic partnership aimed at transforming oncology drug development
Merz Announces Asset Acquisition Agreement with a US Biotechnology Company
Wednesday, April 03, 2024Merz Therapeutics a division of the Frankfurtbased Merz Group has initiated a deal to acquire two established medications from Acorda Therapeutics a Nasdaqlisted company
Mosaic Biosciences Strengthens Its Position in Drug Discovery and Development
Wednesday, April 03, 2024Mosaic Biosciences a prominent player in the field of drug discovery has announced the appointment of two distinguished leaders to its team Dr Malavi Madireddi as Senior Vice President of Drug Discovery
BioInvent Enters Clinical Trial Collaboration and Supply Agreement with MSD to Assess BI-1910 Combined with KEYTRUDA®
Tuesday, April 02, 2024BioInvent International AB a biotechnology company specializing in the development of innovative immunemodulatory antibodies for cancer immunotherapy has announced a collaboration and supply
